Benlysta® Belimumab 400 mg Injection Single-Use Vial 20 mL

Name: Immunosuppressive Agent
Brand: Benlysta®

McKesson #

1184516

Manufacturer #

49401010201

Brand

Benlysta®

Manufacturer

Glaxo Specialty (Medical Benefit)

Country of Origin

Unknown

Application

Immunosuppressive Agent

Container Type

Single-Use Vial

Dosage Form

Injection

Generic Drug Name

Belimumab

NDC Number

49401010201

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

400 mg

Type

Intravenous

UNSPSC Code

51202403

Volume

20 mL

BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: patients aged 5 years and older with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy
BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: adult patients with active lupus nephritis who are receiving standard therapy.
BENLYSTA (belimumab) for injection is a sterile, preservative-free, lyophilized powder for reconstitution and dilution prior to intravenous infusion provided in single‑dose glass vials with a rubber stopper (not made with natural rubber latex) and a flip‑off seal. Each 20‑mL vial contains 400 mg of belimumab.
Requires Refrigeration